Functionally distinct subsets of thymus-derived (T) cells differ with regard to their Ly surface phenotype (1-3)
. Peritoneal T cells of C57BL/6 (B6) mice which are cytotoxic for BALB/c target cells are Ly-l-, Ly-2/3 +, whereas B6 spleen cells which perform a "helper function" in the production of antibody to sheep red blood cells are Ly-1 ÷, Ly-2/3-. We report here that cytotoxic T cells for syngeneic tumor cells belong to a different T-cell subset than cytotoxic cells for allogeneic target cells.
Materials and Methods
Immunization and Microcytotoxicity Assay. B6 sarcoma Meth 4, induced by subcutaneous injection of methylcholanthrene, was in its 5th to 15th transplant generation in syngeneic mice during these studies. (1, 2) . Peritoneal cells from groups of five B6 mice immunized with either Meth 4 cells (immune) or syngeneic spleen cells (nonimmune) were pooled. Peritoneal lymphocytes were obtained by removing glass-adherent cells, as described previously (1, 4) . For pretreatment with antiserum and complement (C), equal volumes of (a) lymphocytes (5 x 108/ml), (b) appropriately diluted antiserum (titers were determined by standard C-dependent cytotoxicity assays and the dilutions chosen for tests covered the range of maximal cytotoxicity for peritoneal lymphocytes), and (c) C (selected rabbit serum [1/15] for mouse antisera, or guinea pig serum [1/3] for rabbit antisera) was mixed and incubated for 45 min at 37°C. The medium was Eagle's balanced salt solution with 2.5% fetal bovine serum, 100 U/ml penicillin, and 100 ~g/ml streptomycin. For control purposes, antisera against reciprocal Ly or Thy-1 alleles, or normal rabbit serum (in the case of rabbit antisera) were used. To analyze the surface phenotype of syngeneic cytotoxic cells, subpopulations of peritoneal lymphocytes were prepared by eliminating cells marked by one or another T-or B-cell surface antigen through the use of cytotoxic antiserum and C (1, 2, 5). Pretreatment with antisera against Thy-1, mouse-specific T-lymphocyte antigen (MSLA) or Ig showed that the cytotoxic cells for syngeneic Meth 4 cells, as in our earlier experiments with allogeneic target cells (1, 4, 6) , have a Thy-1 +, MSLA +, Ig-phenotype (Table I) . Pretreatment of immune B6 lymphocytes (phenotype Ly-1.2,2.2,3.2) with anti-Ly-l.2, anti-Ly-2.2, or anti-Ly-3.2 sera reduced their cytotoxicity for Meth 4 cells (Table II) . Additional confirmation of the specificity of these reactions was obtained in the experiment shown in Fig. 2 . The reduction of B6 T-cell cytotoxicity for Meth 4 cells by treatment with antiLy-l.2 serum was prevented by absorption with B6 thymocytes (phenotype Ly-1.2), but not by absorption with thymocytes from congenic B6/Ly-1.1 mice (1). Similarly, anti-Ly-3.2 was no longer effective in reducing lymphocyte cytotoxicity after absorption with B6 thymocytes (phenotype Ly-3.2), but retained that activity after absorption with B6/Ly-2.1,3.1. These results suggested that Ly-1, as well as Ly-2/3 were represented on the surface of syngeneic cytotoxic cells. To determine whether some cytotoxic cells express Ly-1, and others Ly-2/3, or whether the phenotype of all cytotoxic cells was Ly-l,2,3, experiments of the type shown in Table III were undertaken. Effector cells were pretreated with either anti-Ly-l.2 or anti-Ly-3.2 serum, and then mixed in equal proportions to obtain a mixture that contained Ly-1 cells and Ly-2/3 cells, but not Ly-l,2,3 cells. This mixture (on line 6 in Table III) showed no cytotoxicity, demonstrating that lymphocyte cytotoxicity for syngeneic tumor cells is mediated by cells that carried both Ly-1 and Ly-2/3 on their surface. The results do not rule out the possibility that Ly-l,2,3 T cells are required to cooperate with other T cells in syngeneic cell killing or that an increase in the proportion of suppressor cells might account for the lack of cytotoxicity in the experiment with mixed effector cell populations.
Summary
Our present and previous findings may be summarized as follows: The phenotype of C57BL/6 (B6) cytotoxic cells for allogeneic target cells is Thy-1 +, Ly-l-, Ly-2/3 +, MSLA +, and Ig-. The phenotype of B6 cytotoxic cells for syngeneic tumor cells is Thy-1 +, Ly-1 +, Ly-2/3 +, MSLA +, and Ig-. Thus, differences in Ly phenotype appear to be exhibited not only by cytotoxic T cells as opposed to helper T cells, but also within subcategories of cytotoxic T cells. subcategories of cytotoxic T cells.
